Tharimmune Inc
(THAR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | THAR | AZN | AMGN | GILD | BMY |
| Company | Tharimmune Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 4.41 | 202.52 | 366.66 | 153.42 | 60.00 |
| High | 4.41 | 204.58 | 369.50 | 155.73 | 60.14 |
| Low | 4.20 | 202.10 | 365.18 | 152.26 | 59.25 |
| Latest | 4.22 | 204.44 | 366.68 | 151.38 | 60.12 |
| Change | -0.13 | -0.32 | +0.10 | -4.42 | +0.19 |
| % Change | -2.99% | -0.16% | +0.03% | -2.84% | +0.32% |
| Volume | 102,251 | 555,094 | 199,168 | 1,751,207 | 1,419,576 |
| 20-Day Average Volume | 1,462,736 | 4,504,670 | 3,110,141 | 8,482,859 | 13,067,112 |
| Previous Close | 4.35 | 204.76 | 366.58 | 155.80 | 59.93 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.95 | 188.70 | 351.51 | 140.41 | 56.82 |
| 20-Day Raw Stochastic | 50.00% | 95.45% | 70.89% | 87.69% | 70.08% |
| 20-Day Relative Strength | 56.67 | 64.03 | 60.64 | 68.61 | 62.70 |
| Weighted Alpha | -41.76 | +47.31 | +32.44 | +56.65 | +20.83 |
| Today's Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 40% Buy | 100% Buy | 48% Buy | 40% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.65% since 02/05/26 | +8.84% since 02/05/26 | -0.31% since 02/05/26 | +2.31% since 02/05/26 | -0.03% since 02/05/26 |
| Low | 3.82 on 02/09/26 | 187.06 on 02/09/26 | 361.00 on 02/11/26 | 147.07 on 02/10/26 | 59.25 on 02/12/26 |
| High | 4.83 on 02/10/26 | 204.92 on 02/11/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| 1-Month | |||||
| %Chg | +41.86% since 01/12/26 | +8.78% since 01/12/26 | +12.63% since 01/12/26 | +24.65% since 01/12/26 | +6.70% since 01/12/26 |
| Low | 2.71 on 01/21/26 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 120.22 on 01/13/26 | 53.54 on 01/21/26 |
| High | 5.83 on 02/02/26 | 204.92 on 02/11/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| 3-Month | |||||
| %Chg | +32.61% since 11/12/25 | +16.16% since 11/12/25 | +9.03% since 11/12/25 | +23.84% since 11/12/25 | +21.24% since 11/12/25 |
| Low | 2.18 on 11/20/25 | 175.24 on 11/13/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 5.83 on 02/02/26 | 204.92 on 02/11/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| 6-Month | |||||
| %Chg | +205.00% since 08/12/25 | +35.19% since 08/12/25 | +28.66% since 08/12/25 | +27.32% since 08/12/25 | +27.83% since 08/12/25 |
| Low | 1.08 on 08/19/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 9.08 on 08/25/25 | 204.92 on 02/11/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 164,125 | 317,563,904 | 197,396,352 | 193,297,952 | 122,002,680 |
| Shares Outstanding, K | 37,730 | 1,550,908 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 0 | 54,073,000,000 | 36,751,000,000 | 28,754,000,000 | 48,194,000,000 |
| Annual Net Income | -12,200,000 | 7,035,000,000 | 7,711,000,000 | 480,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,866,000,000 | 7,769,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -2,100,000 | 2,533,000,000 | 1,333,000,000 | 3,052,000,000 | 1,087,000,000 |
| 60-Month Beta | 1.43 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.34 on 11/12/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 03/24/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 23.88 | 16.69 | 18.07 | 9.90 |